BeOne Medicines (BEIGF) Invested Capital (2015 - 2026)
BeOne Medicines (BEIGF) reported Invested Capital of $5.6 billion for Q1 2026, up 31.44% year-over-year from $4.3 billion in Q1 2025, and up 7.81% quarter-over-quarter from $5.2 billion in Q4 2025.
BeOne Medicines (BEIGF) Invested Capital (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of Invested Capital data on file, last reported at $5.6 billion in Q1 2026.
- Invested Capital for Q1 2026 came in at $5.6 billion, up 31.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 31.44% YoY), and the FY2025 annual result was $5.2 billion, up 54.68% from the prior year.
- Invested Capital grew to $5.6 billion in Q1 2026 per BEIGF's latest filing, from $5.2 billion in the prior quarter.
- Over five years, Invested Capital peaked at $6.2 billion in Q1 2022 and troughed at $3.4 billion in Q4 2024.
- A 5-year average of $4.6 billion and a median of $4.3 billion in 2024 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2025: Invested Capital plunged 33.18% in 2022, then soared 54.68% in 2025.
- A 5-year view of Invested Capital shows it stood at $4.4 billion in 2022, then slipped by 3.6% to $4.2 billion in 2023, then fell by 20.48% to $3.4 billion in 2024, then soared by 54.68% to $5.2 billion in 2025, then climbed by 7.81% to $5.6 billion in 2026.
- Business Quant data shows BEIGF's Invested Capital at $5.6 billion in Q1 2026, $5.2 billion in Q4 2025, and $4.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | 502.95 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 5.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Bn |
| Dec 31, 2025 | 5.20 Bn |
| Sep 30, 2025 | 4.16 Bn |
| Jun 30, 2025 | 4.58 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 3.36 Bn |
| Sep 30, 2024 | 4.30 Bn |
| Jun 30, 2024 | 4.22 Bn |
| Mar 31, 2024 | 4.19 Bn |
| Dec 31, 2023 | 4.23 Bn |
| Sep 30, 2023 | 4.09 Bn |
| Jun 30, 2023 | 4.22 Bn |
| Mar 31, 2023 | 4.44 Bn |
| Dec 31, 2022 | 4.38 Bn |
| Sep 30, 2022 | 5.10 Bn |
| Jun 30, 2022 | 5.58 Bn |
| Mar 31, 2022 | 6.18 Bn |
| Dec 31, 2021 | 6.56 Bn |
| Sep 30, 2021 | 3.80 Bn |
| Jun 30, 2021 | 4.04 Bn |